View Single Post
Old 06-25-2007, 04:42 PM   #13
Jean
Senior Member
 
Join Date: Oct 2005
Location: New Jersey
Posts: 3,154
I would consider a second opinion...last August herceptin was approved for early stage bc. It is considered standard of care now for her2 + patients. You may want to pull the report of A/C versus TCH trials
by Dr. Slamon...The TCH proved to be much less risk to the heart than
the A/C chemo treatments. I believe the trial showed a 0 results for
heart problems with the TCH treatment.

I was dx. as a stage 1 with a small tumor 6MM afer biopsey 3MM.
This was back in 2005....at this time Dr. Slamon was advising that
all her2 bc should have herceptin. It took me another year of fighting
hard to get the treatment. I ended up flying out to see Dr. Slamon
who advised TCH. It was very doable and I completed my l yr. of herceptin without any problems.

Bring the research into your onc. and do consider 2nd opinion.
Do not let your dr. sell you the point that due to your tumor being small
and node negative you do not need herceptin etc. There are millions
of cells in one small tumor and we do know that the cancer can pass
via the blood system.

Our site has many articles on this inforamtion.
Wishing you the best of luck.
If you require additional information or help just reach out.
Jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
Jean is offline   Reply With Quote